跳至主要内容
临床试验/CTRI/2018/07/015048
CTRI/2018/07/015048已完成3 期

A randomised controlled trial to compare two different doses of maternal B12 supplementation in improving infant B12 deficiency and neurodevelopment - MATCOBIND

Department of Biotechnology0 个研究点目标入组 708 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
708

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnant women
  • <12 weeks gestation
  • Vegetarian mothers

排除标准

  • Elderly primi mother ( >35 years)
  • 1. Mothers already on B12 supplementation
  • 2. Women with multiple gestation, those diagnosed with chronic medical conditions (diabetes mellitus, hypertension, heart disease, neurological disease or thyroid disease), and those who tested
  • positive for hepatitis B, HIV or syphilis (associated with prematurity, IUGR and other neonatal morbidities which could influence neurodevelopment)
  • 1. Women who anticipate moving out of the city before/ after delivery 2. Women treated for infertility
  • 3. Women with known psychological illnesses including depression

研究者

发起方
Department of Biotechnology

相似试验